| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Tetrachloroethylene | Health-Based | N/A | 9.25 | Mar 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 9.25 | Mar 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 9.25 | Mar 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 9.25 | Mar 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 9.25 | Mar 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 9.25 | Mar 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 7.93 | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 7.93 | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 7.93 | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 7.93 | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 7.93 | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 7.93 | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 8.3 | Sep 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 8.3 | Sep 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 8.3 | Sep 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 8.3 | Sep 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 8.3 | Sep 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 8.3 | Sep 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Tetrachloroethylene | Health-Based | N/A | 9.35 | Jun 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 9.35 | Jun 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 9.35 | Jun 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 9.35 | Jun 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 9.35 | Jun 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 9.35 | Jun 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 6.85 | Mar 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 6.85 | Mar 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 6.85 | Mar 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 6.85 | Mar 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 6.85 | Mar 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 6.85 | Mar 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Tetrachloroethylene | Health-Based | N/A | 8.93 | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 8.93 | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 8.93 | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 8.93 | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 8.93 | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 8.93 | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 7 | Sep 30, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 7 | Sep 30, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 7 | Sep 30, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 7 | Sep 30, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 7 | Sep 30, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 7 | Sep 30, 2021 | Resolved | Liver problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Tetrachloroethylene | Health-Based | N/A | 7.5 | Jun 30, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 7.5 | Jun 30, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 7.5 | Jun 30, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 7.5 | Jun 30, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 7.5 | Jun 30, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 7.5 | Jun 30, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 7.5 | Jun 30, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Health-Based | N/A | 7.5 | Jun 30, 2021 | Resolved | Liver problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |